UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$498M |
| 2 |
Ametek
AME
|
+$445M |
| 3 |
Microsoft
MSFT
|
+$432M |
| 4 |
Apple
AAPL
|
+$209M |
| 5 |
Tesla
TSLA
|
+$198M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$759M |
| 2 |
Accenture
ACN
|
+$529M |
| 3 |
ConocoPhillips
COP
|
+$392M |
| 4 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$324M |
| 5 |
iShares Core S&P Small-Cap ETF
IJR
|
+$310M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.01% |
| 2 | Healthcare | 15.34% |
| 3 | Financials | 12.73% |
| 4 | Consumer Discretionary | 9.85% |
| 5 | Industrials | 8.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VGR
1901
DELISTED
Vector Group Ltd.
VGR
| $819K | ﹤0.01% |
69,086
-2,646
| -4% | -$27.9K |
|
1902
Iovance Biotherapeutics
IOVA
$2.83B
| $819K | ﹤0.01% |
128,171
| – | – |
|
1903
Tootsie Roll Industries
TR
$2.95B
| $819K | ﹤0.01% |
21,648
+6,824
| +46% | +$249K |
|
1904
Scansource
SCSC
$1.11B
| $817K | ﹤0.01% |
27,947
+3,169
| +13% | +$94K |
|
|
TELL
1905
DELISTED
Tellurian Inc.
TELL
| $816K | ﹤0.01% |
485,822
+5,214
| +1% | +$13.1K |
|
1906
Center Bancorp
CNOB
$1.79B
| $812K | ﹤0.01% |
33,538
-2,236
| -6% | -$55K |
|
|
HONE
1907
DELISTED
HarborOne Bancorp
HONE
| $811K | ﹤0.01% |
58,333
+23,694
| +68% | +$338K |
|
1908
Grid Dynamics Holdings
GDYN
$620M
| $810K | ﹤0.01% |
72,149
+8,078
| +13% | +$105K |
|
1909
Enbridge
ENB
$112B
| $808K | ﹤0.01% |
20,670
-2,189
| -10% | -$85.6K |
|
1910
Dime Commercial Bancshares
DCOM
$1.78B
| $806K | ﹤0.01% |
25,330
-1,600
| -6% | -$52.8K |
|
|
DCT
1911
DELISTED
Duck Creek Technologies, Inc. Common Stock
DCT
| $805K | ﹤0.01% |
66,774
| – | – |
|
1912
Tilray
TLRY
$616M
| $798K | ﹤0.01% |
29,657
+5,402
| +22% | +$189K |
|
1913
NRC Health Common Stock
NRC
$453M
| $795K | ﹤0.01% |
21,314
+490
| +2% | +$19K |
|
1914
Sterling Infrastructure
STRL
$16.8B
| $794K | ﹤0.01% |
24,207
| – | – |
|
1915
LivePerson
LPSN
$31.1M
| $793K | ﹤0.01% |
5,212
+296
| +6% | +$47.4K |
|
1916
BridgeBio Pharma
BBIO
$16.7B
| $792K | ﹤0.01% |
103,965
-3,873
| -4% | -$37.1K |
|
1917
Sinclair Inc
SBGI
$1.04B
| $792K | ﹤0.01% |
51,039
-1,569
| -3% | -$27.9K |
|
1918
Fate Therapeutics
FATE
$328M
| $789K | ﹤0.01% |
78,151
-332,742
| -81% | -$6.25M |
|
1919
uniQure
QURE
$3.25B
| $788K | ﹤0.01% |
34,774
+921
| +3% | +$19.9K |
|
|
RADI
1920
DELISTED
Radius Global Infrastructure, Inc. Class A Common Stock
RADI
| $788K | ﹤0.01% |
66,642
| – | – |
|
|
SHOE
1921
Shoe Station Group
SHOE
$425M
| $788K | ﹤0.01% |
+32,937
| New | +$787K |
|
1922
QuinStreet
QNST
$1.25B
| $787K | ﹤0.01% |
54,862
+116
| +0.2% | +$1.47K |
|
1923
Bank First Corp
BFC
$1.7B
| $787K | ﹤0.01% |
8,476
| – | – |
|
1924
Mercury Insurance
MCY
$5.98B
| $785K | ﹤0.01% |
22,941
+1,992
| +10% | +$66.2K |
|
|
SNBR
1925
DELISTED
Sleep Number
SNBR
| $783K | ﹤0.01% |
30,136
+597
| +2% | +$18.1K |
|
Similar funds
UBS AM's Q4 2022 Portfolio in Review
As of Q4 2022, UBS AM held 2,824 positions worth $191B, up 7% from $178B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
UBS AM's Q4 2022 filing shows 88 new, 1,334 increased, 722 reduced and 301 closed positions. Its largest new stake was Ferguson: 543,379 shares worth $69M. The largest sale was Amgen, an estimated $759M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Healthcare and Financials.
- UBS AM's largest Q4 2022 buy was Ferguson: 543,379 shares worth $69M.
- UBS AM added most to Amazon in Q4 2022, an estimated $498M increase.
- UBS AM's biggest Q4 2022 reduction was Accenture, cutting an estimated $529M.
- UBS AM fully exited Amgen in Q4 2022, selling an estimated $759M.
- UBS AM's ten largest holdings make up 19% of its $191B portfolio in Q4 2022.
- UBS AM opened 88 new positions and closed 301 in Q4 2022.
- UBS AM's portfolio value rose 7% quarter-over-quarter to $191B.
Based on UBS AM's 13F filing for Q4 2022, filed 14 Feb 2023.